Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

The biggest fallers on the FTSE 100 were Croda International, down 301p at 2,598p; Rentokil Initial, down 12.9p at 348.1p; ...

Shares of Novo Nordisk that trade in the United States tumbled 21.8% after the Danish company cut its forecast for sales growth this year, in part because of lower expectations for its Wegovy ...

Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes ...

Facing a $70 billion market loss, Novo Nordisk appointed Maziar Mike Doustdar as its new CEO to navigate intensifying ...

Wall Street chugged mostly higher in premarket trading as Chinese and U.S. officials begin a second day of trade talks.

Novo Nordisk's newly appointed CEO, Maziar Mike Doustdar, confronts the daunting task of revitalizing the company's declining sales and share prices. Despite investor skepticism due to his lack of U.S ...

Tariffs, including the 15% rate for most imports from the EU, would raise consumer prices by 1.8% in the short run, according to the Yale Budget Lab.

Knockoff copies of Novo’s weight loss medicine Wegovy have held back sales and put the drugmaker on the back foot in its ...

The Danish-maker of Wegovy and Ozempic has warned that its full-year sales and profits will not grow as quickly as expected ...

The biggest fallers on the FTSE 100 were Croda International, down 301.00p at 2,598.00p, Rentokil Initial, down 12.90p at 348.10p, Glencore, down 10.80p at 305.90p, Unite Group, down 21.50p at 764.50p ...